ARCALIS, Inc.

Exhibitors

Information

ARCALIS is a CDMO specializing in messenger RNA (mRNA) Medicines & Vaccines. Founded as a joint venture between Axcelead, Inc., Japan's first drug discovery platform company, and Arcturus Therapeutics, a US-based clinical mRNA medicines company.In July 2023, ARCALIS established a GMP mRNA drug substance manufacturing facility in Japan, further strengthening our capabilities. In 2024, we achiev...

Social media

Contact details

https://corp.arcalis.co.jp/en
Japan

Products

Sessions

Building a Robust mRNA CDMO: Advancing Scalable and End-to-End Manufacturing Solutions

Tuesday, May 20, 2025 7:35 PM to 7:50 PM
Innovation Theater
Satoshi Takamatsu · ARCALIS, Inc.

Team

HY
Hideki Yoshihisa
Head of Sales and MarketingARCALIS, Inc.
Masatoshi Mutazono
Masatoshi Mutazono
Sales and MarketingARCALIS, Inc.
Satoshi Takamatsu
Satoshi Takamatsu
Representative Director, President and CEOARCALIS, Inc.

Log in

See all the content and easy-to-use features by logging in or registering!